Cervical Cancer in Nigeria: Key Insights from Petra Ibum Adjah
Petra Ibum Adjah highlights critical facts about cervical cancer and the WHO's strategy for its elimination in Nigeria.
Only 14% of Nigerian women aged 25-49 have undergone a Pap smear.
The HPV vaccine is now available for free to girls aged 9-14.
3.5% of Nigerian women are carriers of high-risk HPV strains linked to cervical cancer.
Petra Ibum Adjah, the Programs and Communications Manager at Pink Africa Foundation, has emphasized the urgent need to address cervical cancer in Nigeria. In a recent discussion, she outlined the World Health Organization's 90-70-90 strategy aimed at eliminating cervical cancer in low- and middle-income countries by the year 2030. This strategy includes ensuring that 90% of girls receive HPV vaccinations by age 15, 70% of women undergo high-performance screening by age 35, and that 90% of women diagnosed with cervical cancer receive necessary treatment.
Despite the availability of preventive measures, the statistics reveal a concerning picture. Approximately 14% of women aged 25 to 49 in Nigeria have never had a Pap smear test. Furthermore, awareness of cervical cancer screening remains alarmingly low, with community awareness levels ranging from just 6.9% to 38.6%. These figures highlight the critical need for enhanced education and outreach programs to improve screening rates and awareness about cervical cancer.
On a more positive note, the introduction of the single-dose HPV vaccine, which is now offered free of charge at Primary Health Care facilities for girls aged 9 to 14, marks a significant step forward. To date, around 17 million girls have received the vaccine, which is crucial in preventing cervical cancer. However, the challenge remains in ensuring that all eligible girls have access to this life-saving vaccine.
Moreover, it is estimated that 3.5% of women in Nigeria are carriers of the high-risk HPV strains, HPV-16 and HPV-18, which are responsible for nearly 67% of invasive cervical cancer cases in the country. This underscores the importance of not only vaccination but also regular screening and early detection to manage and treat precancerous lesions effectively.
Looking ahead, it is essential for stakeholders to collaborate and expand services related to cervical cancer prevention and treatment. The Pink Africa Foundation, along with other organizations, is working to close the care gap through health education, advocacy, and providing free screenings and treatments. The successful implementation of these strategies is vital to ensure that no woman or girl is left behind in the fight against cervical cancer in Nigeria.




